September 27, 2016 12:10 PM ET

Biotechnology

Company Overview of ImmunoBiosciences, Inc.

Company Overview

ImmunoBiosciences, Inc. develops a vaccine platform technology solution to create vaccines to combat diseases. Its technology combines specific antigens (viruses or bacteria) with corresponding neutralizing antibodies in a complex to create vaccines. The company offers its solutions in the areas of respiratory syncytial virus, seasonal/pandemic influenza, and dengue fever. The company was incorporated in 2001 and is based in Raleigh, North Carolina.

920 Main Campus Drive

Suite 405

Raleigh, NC 27606-5213

United States

Founded in 2001

Phone:

919-398-6233

Fax:

919-398-6255

Key Executives for ImmunoBiosciences, Inc.

Founder, Chairman, Chief Executive Officer and President
Acting Vice President of Business Development & Licensing
Acting Vice President of Research & Development
Age: 61
Compensation as of Fiscal Year 2016.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3D Bio Holdings LLC United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact ImmunoBiosciences, Inc., please visit www.immunobiosciences.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.